100 doses of Ebola drug available: Sarepta CEO By: CNBC.com News September 30, 2014 at 18:23 PM EDT The company behind one of the most promising Ebola treatments has enough doses to handle about 100 patients, Sarepta Therapeutics CEO Chris Garabedian says. Read More >> Related Stocks: Sarepta Therapeutics